— Know what they know.
Not Investment Advice

LNDC NASDAQ

Landec Corporation
1W: -3.0% 1M: +7.1% 3M: -24.2% 1Y: -7.9% 3Y: -19.5% 5Y: -28.5%
$8.76
Last traded 2022-11-14 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $263.6M mcap · 20M float · 0.327% daily turnover

Cash Flow Trends

Operating Cash Flow
-$206K +5.1% ▲
Capital Expenditures
$13M +25.1% ▲
5Y CAGR: -12.9%
Free Cash Flow
-$14M +24.9% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$197K +0.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$33M-$97M-$33M$18K-$39M
Depreciation & Amort.$20M$18M$20M$9M$8M
Stock-Based Comp.$0$0$0$6M$10M
Change in Working Capital$9M-$7M$0$0$0
Other Non-Cash Items$23M$66M$0$0$20M
Operating Cash Flow$15M-$24M$15M-$217K-$206K
— Investing Activities —
Capital Expenditures-$24M-$28M-$24M-$18M-$13M
Acquisitions (Net)$0$64M$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$45M$0$0$0
Other Investing$13M$1M$13M$0$7M
Investing Cash Flow-$11M$82M-$11M-$18M-$6M
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$3M-$57M-$3M$0$6M
Financing Cash Flow-$3M-$57M-$3M$0$6M
Net Change in Cash$742K$348K$742K$0-$197K
Cash End of Period$1M$2M$1M$0$8M
Free Cash Flow-$9M-$53M-$9M-$18M-$14M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms